Reduced expression of PHD3 was also identified in immunologically “cold” tumors (i.e. those with low CD8+ T cell signatures) from patients with colon adenocarcinoma or clear cell renal cell carcinoma, but not melanoma (24). Here, EGLN3 is linked to colon adenocarcinoma.